Balance Sheet (Annual)

ASX:RMD / RESMED INC Balance Sheet shows account balances for the company at points in time. Balance Sheet data includes Assets, Current Assets, Fixed Assets, Property, Plant and Equipment (PPE), Inventory, Intangibles, Liabilities, Current Liabilities, Debt, Capital Lease Obligations, Common Stock, Retained Earnings, Treasury Stock, and Shareholders Equity.

All numbers are times 1,000 except per share units.

2012 2013 2014 2015 2016 2017 2018
Assets
  Assets Current
    Cash And Cash Equivalents At Carrying Value 809,541 876,048 905,730 717,249 731,434 821,935 188,701
    Accounts Receivable Net Current - - 359,593 362,568 382,086 450,530 483,681
    Inventory Net 174,351 145,847 165,418 246,859 224,456 268,319 268,701
    Prepaid Expense And Other Assets Current - - 78,707 81,168 81,743 103,219 124,634
    Assets Current 1,361,151 1,448,849 1,556,209 1,444,182 1,419,719 1,644,003 1,065,717
  Assets Noncurrent
    Property Plant And Equipment Net 434,363 411,433 434,277 387,758 384,276 394,241 386,550
    Goodwill 256,209 274,829 289,312 264,261 1,059,245 1,064,874 1,068,944
    Finite Lived Intangible Assets Net 54,827 49,639 45,198 47,142 299,808 261,800 215,184
    Deferred Tax Assets Net Noncurrent 23,500 20,053 18,755 12,528 55,496 61,503 53,818
    Other Assets Noncurrent 7,819 5,918 17,211 28,389 40,391 42,066 273,710
    Assets Noncurrent 776,718 761,872 804,753 740,078 1,839,216 1,824,484 1,998,206
  Assets 2,137,869 2,210,721 2,360,962 2,184,260 3,258,935 3,468,487 3,063,923
Liabilities And Stockholders Equity
  Liabilities Current
    Accounts Payable Current 55,006 60,688 85,405 81,112 92,571 92,763 92,723
    Accrued Liabilities Current 127,381 137,674 130,656 132,976 156,805 186,295 185,805
    Deferred Revenue Current 41,563 44,953 42,370 36,097 50,009 51,918 60,828
    Accrued Income Taxes Current 27,777 30,090 10,392 16,278 39,166 29,150 160,427
    Liabilities Current 252,852 574,049 269,558 267,259 638,551 360,126 511,249
  Liabilities Noncurrent
    Deferred Revenue Noncurrent 14,384 11,928 16,352 19,284 40,281 53,235 71,596
    Deferred Tax Liabilities Noncurrent 8,843 9,895 10,716 8,062 9,061 13,822 13,084
    Other Liabilities Noncurrent - - - - 1,211 2,427 924
    Long Term Debt 250,835 300,786 300,788 300,594 - - 269,988
    Accrued Income Taxes Noncurrent 3,380 3,564 5,318 1,754 - - 138,102
    Liabilities Noncurrent 277,390 26,156 333,156 329,694 925,553 1,148,095 493,694
  Liabilities 530,242 600,205 602,714 596,953 1,564,104 1,508,221 1,004,943
  Commitments And Contingencies - - - - - - -
  Stockholders Equity
    Preferred Stock Value 0 - - - - - -
    Common Stock Value Outstanding 568 568 561 562 563 569 571
    Additional Paid In Capital Common Stock 899,717 1,025,064 1,117,644 1,228,795 1,303,238 1,379,130 1,450,821
    Retained Earnings Accumulated Deficit 1,366,712 1,576,641 1,780,396 1,976,020 2,160,299 2,316,237 2,432,328
    Treasury Stock Value 895,826 1,083,845 1,291,910 1,444,554 1,546,611 1,546,611 1,600,412
    Accumulated Other Comprehensive Income Loss Net Of Tax 236,456 92,088 151,557 -173,516 -222,658 -189,059 -224,328
    Stockholders Equity - - 1,758,248 1,587,307 1,694,831 1,960,266 2,058,980
  Liabilities And Stockholders Equity 2,137,869 2,210,721 2,360,962 2,184,260 3,258,935 3,468,487 3,063,923

Peers - Surgical and Medical Instruments and Apparatus (3841)

Related News Stories

ResMed Unveils AirFit F30, Expands AirFit Mask Portfolio

2018-09-18 zacks
ResMed (RMD - Free Report) recently expanded its AirFit mask portfolio with the introduction of its first minimal-contact full face CPAP mask — AirFit F30. The company plans to launch the product in selected geographies in late-2018. (1-0)

UPDATE 1-NZ's Fisher & Paykel cuts FY guidance on ResMed-linked legal costs

2018-09-02 reuters
Sept 3 (Reuters) - New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.

NZ's Fisher & Paykel Healthcare cuts FY guidance on higher expected legal costs

2018-09-02 reuters
Sept 3 (Reuters) - New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.

Tap the Sleep Apnea Devices Market Boom With These 3 Stocks

2018-08-27 zacks
Favorable consumer behavior, growing demand for liquid biopsy tests along with deferred implementation of an industry-wide Medical Device tax have created a safe haven for medical device companies. As the U.S. Medical Device industry is likely to reach a worth of $173 billion by 2019, per Emergo, it is currently enjoying the investment world’s attention.

Masimo's SET Pulse Oximetry Detects Sleep Apnea in Children

2018-08-15 zacks
Masimo Corporation (MASI - Free Report) recently announced that its SET Measure-through Motion and Low Perfusion pulse oximetry might be a useful initial screening method to identify children with Down Syndrome (DS) who are at a high risk of obstructive sleep apnea (OSA).